Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$3.54 - $8.08 $3,207 - $7,320
-906 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$7.88 - $14.0 $394 - $700
50 Added 5.84%
906 $7,000
Q2 2021

Nov 12, 2021

SELL
$13.81 - $23.25 $925 - $1,557
-67 Reduced 7.26%
856 $11,000
Q1 2021

Nov 12, 2021

BUY
$17.65 - $24.16 $16,290 - $22,299
923 New
923 $19,000

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.